Effect of stereoisomerism on the cellular pharmacology of β-enantiomers of cytidine analogs in Hep-G2 cells
- 10 January 1997
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 53 (1) , 75-87
- https://doi.org/10.1016/s0006-2952(96)00653-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- The Effect of Absolute Configuration on the Anti-HIV and Anti-HBV Activity of Nucleoside AnaloguesAntiviral Chemistry and Chemotherapy, 1995
- Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2.2.15 (subclone P5A) cellsAntimicrobial Agents and Chemotherapy, 1994
- Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virusAntimicrobial Agents and Chemotherapy, 1993
- The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineAntimicrobial Agents and Chemotherapy, 1992
- Comparison of cytotoxicity of the (−)- and (+)- enantiomer of 2′,3′- dideoxy-3′-thiacytidine in normal human bone marrow progenitor cellsBiochemical Pharmacology, 1992
- Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineAntimicrobial Agents and Chemotherapy, 1992
- Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.Published by Elsevier ,1992
- Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytesAntimicrobial Agents and Chemotherapy, 1992